Triosyn

About:

Triosyn Corp. has developed a novel technology to kill disease-causing microorganisms and to treat microbial infections.

Website: http://www.triosyn.com

Top Investors: BDC Venture Capital, CDP Capital Technology Ventures, SL Ventures, Innovatech Grand Montreal

Description:

Triosyn Corp. has developed a novel technology to kill disease-causing microorganisms and to treat microbial infections. Its core technology, Triosyn(R) resin, is an iodinated polymer that interacts with and kills all microorganisms on contact, and due to a proprietary demand-release delivery mechanism provides enhanced safety to humans and the environment. The basic formulation of Triosyn(R) has been registered with the EPA and further registration of Triosyn(R) applications are in process.